Abstract
Pancreatic cancer is caused by mutations in specific cancer genes. While these cancer genes are often categorized into those that are inherited versus somatically acquired, they may also be categorized into those that occur during carcinogenesis versus those that accumulate during clonal progression. This newfound approach to understanding pancreatic cancer genetics now opens the door to understanding those events that play a role specifically in progression to metastatic disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, Horner J et al (2003) Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 17(24):3112–3126
Balakrishnan A, Bleeker FE, Lamba S, Rodolfo M, Daniotti M, Scarpa A et al (2007) Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Res 67(8):3545–3550
Bosetti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP, Boffetta P (2012) Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog 51(1):3–13
Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB et al (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8(1):27–32
Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, Stebbings LA et al (2010) The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 467(7319):1109–1113
de Jong MC, Farnell MB, Sclabas G, Cunningham SC, Cameron JL, Geschwind J-F et al (2010a) Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis. Ann Surg 252(1):142–148
de Jong MC, Tsai S, Cameron JL, Wolfgang CL, Hirose K, van Vledder MG et al (2010b) Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis. J Surg Oncol 102(3): 256–263
Embuscado EE, Laheru D, Ricci F, Yun KJ, de Boom Witzel S, Seigel A et al (2005) Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biol Ther 4(5):548–554
Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M et al (2007) Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 67(5):2187–2196
Fidler IJ, Hart IR (1982) Biological diversity in metastatic neoplasms: origins and implications. Science 217(4564):998–1003
Garcia-Porta J, Litvinchuk SN, Crochet PA, Romano A, Geniez PH, Lo-Valvo M et al (2012) Molecular phylogenetics and historical biogeography of the west-palearctic common toads (Bufo bufo species complex). Mol Phylogenet Evol 63(1):113–130
Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E et al (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883–892
Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE (1998) Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas. Cancer Res 58(23):5329–5332
Goh AM, Coffill CR, Lane DP (2011) The role of mutant p53 in human cancer. J Pathol 223(2):116–126
Hahn SA, Schutte M, Hoque AT, Moskaluk CA, da Costa LT, Rozenblum E et al (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271(5247):350–353
Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362(17):1605–1617
Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH et al (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7(5):469–483
Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S (2006) Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 10(4):511–518
Hruban RH, Goggins M, Parsons J, Kern SE (2000) Progression model for pancreatic cancer. Clin Cancer Res 6(8):2969–2972
Hruban RH, Adsay NV, Albores-Saavedra J, Compton C, Garrett ES, Goodman SN et al (2001) Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25(5):579–586
Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM et al (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27(11):1806–1813
Ijichi H, Chytil A, Gorska AE, Aakre ME, Fujitani Y, Fujitani S et al (2006) Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev 20(22):3147–3160
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
Jones S, Zhang X, Parsons DW, Lin JC-H, Leary RJ, Angenendt P et al (2008a) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321(5897):1801–1806
Jones S, Chen W-D, Parmigiani G, Diehl F, Beerenwinkel N, Antal T et al (2008b) Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci USA 105(11):4283–4288
Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW et al (2009) Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324(5924):217
Jones S, Li M, Parsons DW, Zhang X, Wesseling J, Kristel P et al (2012) Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat 33(1):100–103
Jonson T, Albrechtsson E, Axelson J, Heidenblad M, Gorunova L, Johansson B et al (2001) Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas. Int J Oncol 19(1):71–81
Kanda M, Matthaei H, Wu J, Hong SM, Yu J, Borges M et al (2012) Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 142(4):730–733.e9
Katz MHG, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA et al (2009) Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16(4):836–847
Kim WY, Sharpless NE (2006) The regulation of INK4/ARF in cancer and aging. Cell 127(2):265–275
Krumbholz A, Bininda-Emonds ORP, Wutzler P, Zell R (2009) Phylogenetics, evolution, and medical importance of polyomaviruses. Infect Genet Evol 9(5):784–799
Little EC, Wang C, Watson PM, Watson DK, Cole DJ, Camp ER (2012) Novel immunocompetent murine models representing advanced local and metastatic pancreatic cancer. J Surg Res 176(2):359–366
Maitra A, Hruban RH (2008) Pancreatic cancer. Annu Rev Pathol 3:157–188
Maitra A, Adsay NV, Argani P, Iacobuzio-Donahue C, De Marzo A, Cameron JL et al (2003) Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 16(9):902–912
Malvezzi M, Arfé A, Bertuccio P, Levi F, La Vecchia C, Negri E (2011) European cancer mortality predictions for the year 2011. Ann Oncol 22(4):947–956
Massagué J (2008) TGFbeta in cancer. Cell 134(2):215–230
Matthaei H, Schulick RD, Hruban RH, Maitra A (2011) Cystic precursors to invasive pancreatic cancer. Nat Rev Gastroenterol Hepatol 8(3):141–150
McDermott U, Downing JR, Stratton MR (2011) Genomics and the continuum of cancer care. N Engl J Med 364(4):340–350
Meyerson M, Gabriel S, Getz G (2010) Advances in understanding cancer genomes through second-Âgeneration sequencing. Nat Rev Genet 11(10):685–696
Morton JP, Timpson P, Karim SA, Ridgway RA, Athineos D, Doyle B et al (2010) Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA 107(1):246–251
Mudali SV, Fu B, Lakkur SS, Luo M, Embuscado EE, Iacobuzio-Donahue CA (2006) Patterns of EphA2 protein expression in primary and metastatic pancreatic carcinoma and correlation with genetic status. Clin Exp Metastasis 23(7–8):357–365
Murchison EP, Schulz-Trieglaff OB, Ning Z, Alexandrov LB, Bauer MJ, Fu B et al (2012) Genome sequencing and analysis of the tasmanian devil and its transmissible cancer. Cell 148(4):780–791
Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J et al (2011) Tumour evolution inferred by single-cell sequencing. Nature 472(7341):90–94
Neilsen PM, Noll JE, Suetani RJ, Schulz RB, Al-Ejeh F, Evdokiou A et al (2011) Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome. Oncotarget 2(12):1203–1217
Nguyen DX, Massagué J (2007) Genetic determinants of cancer metastasis. Nat Rev Genet 8(5):341–352
Padua D, Massagué J (2009) Roles of TGFbeta in metastasis. Cell Res 19(1):89–102
Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O et al (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269(9):6271–6274
Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9(4):265–273
Redston MS, Caldas C, Seymour AB, Hruban RH, da Costa L, Yeo CJ et al (1994) p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res 54(11):3025–3033
Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9(5):402–412
Schubbert S, Shannon K, Bollag G (2007) Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7(4):295–308
Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK et al (1997) Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 57(15):3126–3130
Siegel PM, Massagué J (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3(11):807–821
Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA et al (2000) Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4(6):567–579
Stathis A, Moore MJ (2010) Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 7(3):163–172
Su GH, Hilgers W, Shekher MC, Tang DJ, Yeo CJ, Hruban RH et al (1998) Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res 58(11):2339–2342
Su GH, Hruban RH, Bansal RK, Bova GS, Tang DJ, Shekher MC et al (1999) Germline and somatic mutations of the STK11/LKB1 Peutz–Jeghers gene in pancreatic and biliary cancers. Am J Pathol 154(6):1835–1840
Subarsky P, Hill RP (2003) The hypoxic tumour microenvironment and metastatic progression. Clin Exp Metastasis 20(3):237–250
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet 378(9791):607–620
Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408(6810):307–310
Wilentz RE, Geradts J, Maynard R, Offerhaus GJ, Kang M, Goggins M et al (1998) Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res 58(20):4740–4744
Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J et al (2006) 1423 Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10(9):1199–1210, discussion 1210–1
Winter JM, Brennan MF, Tang LH, D’Angelica MI, Dematteo RP, Fong Y et al (2012) Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Ann Surg Oncol 19(1):169–175
Yachida S, Iacobuzio-Donahue CA (2009) The pathology and genetics of metastatic pancreatic cancer. Arch Pathol Lab Med 133(3):413–422
Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B et al (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467(7319):1114–1117
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Iacobuzio-Donahue, C.A. (2013). The Genetics of Pancreatic Cancer Progression. In: Simeone, D., Maitra, A. (eds) Molecular Genetics of Pancreatic Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6549-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6549-2_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6548-5
Online ISBN: 978-1-4614-6549-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)